Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 279

Sort by

Sort Order Select

Journal Articles

Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Comparing Post-Transplant Cyclophosphamide Versus Anti-T-Lymphocyte Globulin As Graft-Versus-Host Disease Prophylaxis in a Retrospective Cohort Study

Rashit Bogdanov, PhD, Saskia Leserer, Evren Bayraktar, PhD, Nikolaos Tsachakis-Mück, Lara Kasperidus, PhD, Markus Ditschkowski, PhD, Dietrich W. Beelen, Amin T. Turki, MD PhD

Blood (2019) 134 (Supplement_1): 3289.

https://doi.org/10.1182/blood-2019-130623

Published: 2019

Journal Articles

Universal' Fratricide-Resistant CAR T Cells Against T Cell Leukemia Generated By Coupled & Uncoupled Deamination Mediated Base Editing

Christos Georgiadis, PhD, Jane Rasaiyaah, PhD, Soragia Athina Gkazi, PhD, Roland Preece, Annie Etuk, PhD, Abraham Christi, Waseem Qasim, MBBS, PhD

Blood (2019) 134 (Supplement_1): 3219.

https://doi.org/10.1182/blood-2019-130057

Published: 2019

Journal Articles

Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials

Blood (2019) 134 (Supplement_1): 4525.

https://doi.org/10.1182/blood-2019-129488

Published: 2019

Journal Articles

Increased Incidence of Viral Reactivation after T Cell Replete Haploidentical Stem Cell Transplantation in Association with Delayed Immune Reconstitution

Ioannis Tsonis, MD, Dimitrios Karakasis, MD, Maria Bouzani, MD, Chara Giatra, MD, Zois Mellios, MD, Georgia Tounta, MD, Tatiana Tzenou, MD, Dimitra Oikonomopoulou, MD, Eirini Grispou, Maria Katsareli, Maria-Eleni Karatza, Kimon Fountoulis, MD, Themistoklis Karmiris, MD, Stavros Gigantes, MD, Ioannis Baltadakis, MD

Blood (2019) 134 (Supplement_1): 4511.

https://doi.org/10.1182/blood-2019-131127

Published: 2019

Journal Articles

Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients

Ying Wang, Jiang Cao, MD, Yan Zhiling, MD, Jianlin Qiao, PhD, Deipeng Li, MD, Zhenyu Li, MD, Kailin Xu, MD

Blood (2019) 134 (Supplement_1): 1301.

https://doi.org/10.1182/blood-2019-127808

Published: 2019

Journal Articles

Modeling of Immune Reconstitution Post CD34 Selected Stem Cell Transplantation in Pediatric Patients with Severe Combined Immune Deficiency

Jean-Sebastien Diana, MD, Naim Bouazza, PhD, Chloé Couzin, MD, Martin Castelle, MD, Alessandra Magnani, MD PhD, Elisa Magrin, PhD, Laure Joseph, MD, Marianne Delville, MD, Francois Lefrere, MD, jean-Marc Treluyer, MD PhD, Capucine Picard, MD PhD, Despina Moshous, MD PhD, Isabelle André, PhD, Stephane Blanche, MD, Benedicte Neven, MD PhD, Marina Cavazzana, MD PhD

Blood (2019) 134 (Supplement_1): 5668.

https://doi.org/10.1182/blood-2019-127974

Published: 2019

Journal Articles

Early Immune Reconstitution after Haplo-Identical Hematopoietic Stem Cell Transplantation (HCT) with Post-Transplant Cyclophosphamide (PTCY) Does Not Improve Overall Survival Compared to Matched Unrelated Donor HCT Recipients Receiving Thymoglobulin Prophylaxis (ATG)

Yasser Khaled, MD, Joshua Boss, RN, OCN, BMTCN, Poojitha Valasareddy, MD, Arnel Pallera, MD, Robert Johnson, MD, Deniscer Peeler, LPN, Jason C. Chandler, MD, Joel Gradowski, MD

Blood (2019) 134 (Supplement_1): 5676.

https://doi.org/10.1182/blood-2019-131954

Published: 2019

Journal Articles

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Divaya Bhutani, MD, Christian Gordillo, BS, Suzanne Lentzsch, MD PhD, Ran Reshef, MDMSc, Markus Y Mapara, MD PhD

Blood (2019) 134 (Supplement_1): 2043.

https://doi.org/10.1182/blood-2019-132113

Published: 2019

Journal Articles

Immune Reconstitution and Long-Term Outcomes Following Allo-HCT with TLI-ATG and Post-Transplant Rituximab

Vanessa E Kennedy, MD, Sally Arai, MD, David B Miklos, MD PhD, Fang Wu

Blood (2019) 134 (Supplement_1): 1996.

https://doi.org/10.1182/blood-2019-129804

Published: 2019

Journal Articles

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Debora Basilio Basilio-Queiros, MSc, Susanne Luther, Arnold Ganser, MD, Eva M Weissinger, MD

Blood (2019) 134 (Supplement_1): 1939.

https://doi.org/10.1182/blood-2019-121914

Published: 2019

Journal Articles

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT

James Aries, Sarah Charrot, Jennifer Ball, Matthew Mee, Symeon Theocharidis, Sofie Van Gassen, Sameena Iqbal, John G. Gribben, MD DSc, Jeff Davies, MBBS, PhD

Blood (2019) 134 (Supplement_1): 595.

https://doi.org/10.1182/blood-2019-124875

Published: 2019

Journal Articles

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Francoise Bernaudin, MD, Azadeh Djavidi, MD, Cécile Arnaud, MD, Annie Kamdem, MD, Isabelle Hau, MD, Corinne Pondarré, MD PhD, Jean-Paul Vernant, MD, Mathieu Kuentz, MD, Nathalie Dhedin, MD, Jean-Hugues Dalle, MD PhD, Eliane Gluckman, Gerard Socie, MD PhD

Blood (2019) 134 (Supplement_1): 2253.

https://doi.org/10.1182/blood-2019-125316

Published: 2019

Journal Articles

Scheinberg DA. Immune reconstitution and remission in CML. Blood . 2017;129(9):1064-1065.

Blood (2018) 132 (22): 2419.

https://doi.org/10.1182/blood-2018-10-879049

Published: 2018

Journal Articles

Uncovering the Molecular Signature of Pathogenic Tissue-Infiltrating T Cells during Acute Graft-Versus-Host Disease

Victor Tkachev, PhD, Scott N Furlan, MD, E. Lake Potter, Hengqi Zheng, MD, Daniel J Hunt, Lucrezia Colonna, PhD, Agne Taraseviciute, MD PhD, Judith M Carlson, BS, Kayla Betz, Alison Yu, PhD, Michelle Hoffman, MS, Audrey Baldessari, DVM, Sarah Herrin, Joe Olvera, Chad Littlewood, Christopher English, Bruce R. Blazar, MD, Mario Roederer, PhD, Leslie Kean, MD PhD

Blood (2018) 132 (Supplement 1): 805.

https://doi.org/10.1182/blood-2018-99-113652

Published: 2018

Journal Articles

Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation

Lia Minculescu, MD, Hanne Vibeke Marquart, MD PhD, Lars Peter Ryder, MSc, PhD, Ida Schjødt, MD PhD, Lone Smidstrup Friis, MD PhD, Brian Thomas Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc., Niels Smedegaard Andersen, MD PhD, Eva Kannik Hastrup, MD PhD, Anne Fischer-Nielsen, MD PhD, Henrik Sengeloev, MD DMSc

Blood (2018) 132 (Supplement 1): 3396.

https://doi.org/10.1182/blood-2018-99-111777

Published: 2018

Journal Articles

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Debora Queiros, MSc, Susanne Luther-Wolf, Eva M Weissinger, MD, Arnold Ganser, MD

Blood (2018) 132 (Supplement 1): 3327.

https://doi.org/10.1182/blood-2018-99-110779

Published: 2018

Journal Articles

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Moniek De Witte, MD PhD, Anna Van Rhenen, MD PhD, Geerte Van Sluis, MD PhD, Rick Admiraal, MD PhD, Lotte van der Wagen, MD, Eefke J. Petersen, MD PhD, Reinier Raymakers, MD PhD, Monique C Minnema, MD PhD, Anke Janssen, MD, Kasper Westinga, BSc, Constantijn J.M. Halkes, MD, J.H. Frederik Falkenburg, MD PhD, Jaap Jan Boelens, MD PhD, Jurgen Kuball, MD

Blood (2018) 132 (Supplement 1): 2164.

https://doi.org/10.1182/blood-2018-99-112758

Published: 2018

Journal Articles

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

Mahasweta Gooptu, MD, Haesook T. Kim, PhD, Alan Howard, PhD, Sung W. Choi, MD MS, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD PhD, Corey S. Cutler, MD MPH

Blood (2018) 132 (Supplement 1): 2110.

https://doi.org/10.1182/blood-2018-99-115662

Published: 2018

Journal Articles

Evaluation of Donor CD4 + CD25 + Foxp3 + Regulatory T Cells and CD3 - CD56 + NK Cells on Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Fumihito Tajima, MD PhD, Koji Adachi, MD PhD, Takaya Nishio, PhD, Toshio Kawatani, MD PhD, Junji Suzumiya, MD PhD

Blood (2018) 132 (Supplement 1): 5726.

https://doi.org/10.1182/blood-2018-99-112735

Published: 2018

Journal Articles

Prognostic Significance of Early Immune Reconstitution in Newly Diagnosed Multiple Myeloma

Blood (2018) 132 (Supplement 1): 3158.

https://doi.org/10.1182/blood-2018-99-113970

Published: 2018

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Comparing Post-Transplant Cyclophosphamide Versus Anti-T-Lymphocyte Globulin As Graft-Versus-Host Disease Prophylaxis in a Retrospective Cohort Study

Universal' Fratricide-Resistant CAR T Cells Against T Cell Leukemia Generated By Coupled & Uncoupled Deamination Mediated Base Editing

Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials

Increased Incidence of Viral Reactivation after T Cell Replete Haploidentical Stem Cell Transplantation in Association with Delayed Immune Reconstitution

Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients

Modeling of Immune Reconstitution Post CD34 Selected Stem Cell Transplantation in Pediatric Patients with Severe Combined Immune Deficiency

Early Immune Reconstitution after Haplo-Identical Hematopoietic Stem Cell Transplantation (HCT) with Post-Transplant Cyclophosphamide (PTCY) Does Not Improve Overall Survival Compared to Matched Unrelated Donor HCT Recipients Receiving Thymoglobulin Prophylaxis (ATG)

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Immune Reconstitution and Long-Term Outcomes Following Allo-HCT with TLI-ATG and Post-Transplant Rituximab

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Scheinberg DA. Immune reconstitution and remission in CML. Blood . 2017;129(9):1064-1065.

Uncovering the Molecular Signature of Pathogenic Tissue-Infiltrating T Cells during Acute Graft-Versus-Host Disease

Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

Evaluation of Donor CD4 + CD25 + Foxp3 + Regulatory T Cells and CD3 - CD56 + NK Cells on Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Significance of Early Immune Reconstitution in Newly Diagnosed Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology